FDA Inspection
IntelliPharmaCeutics Corp.IntelliPharmaCeutics Corp. – FDA Inspection, Nov 18, 2010
Record Details
This FDA Inspection record concerns IntelliPharmaCeutics Corp., with an inspection on November 18, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- IntelliPharmaCeutics Corp.
- Inspection Date
- November 18, 2010
- Product Type
- Drugs
View Company Profile
ID · d291354e-811b-499e-be41-64f468bb866b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 698518
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of IntelliPharmaCeutics Corp.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 14, 2017 | Not classified | Office of Inspections and Investigations | |
| May 24, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for IntelliPharmaCeutics Corp.
- FDA Inspection 1190656 - 2022-09-26
- FDA Inspection 1095607 - 2019-06-14
- FDA Inspection 1027099 - 2017-07-14
- FDA Inspection 885403 - 2014-05-24
- FDA Inspection 737274 - 2011-07-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.